Sector Update: Health Care Stocks Mixed Premarket Wednesday

MT Newswires Live05-27

Healthcare stocks were mixed premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.2% lower and the iShares Biotechnology ETF (IBB) up 0.5%.

Guardant Health (GH) shares were up more than 5% after the company said its Shield blood test has been included in the American Cancer Society's updated Colorectal Cancer Screening guidelines.

TG Therapeutics' (TGTX) Phase 3 ENHANCE trial met its primary endpoint, demonstrating bioequivalent drug exposure between the approved two-infusion initiation regimen for Briumvi and a proposed single Day 1 infusion dosing schedule, the company said. TG Therapeutics stock was up more than 1% pre-bell.

Nuvalent (NUVL) shares were up more than 1% after the company said the US Food and Drug Administration accepted for filing its New Drug Application for neladalkib, an investigational ALK-selective inhibitor in tyrosine kinase inhibitor pre-treated advanced ALK-positive non-small cell lung cancer.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment